CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Adenoma, Islet Cell D007516 7 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Perlmann P et al. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. 1972 Transplant Rev pmid:4617353
Henney CS On the mechanism of T-cell mediated cytolysis. 1973 Transplant Rev pmid:4135078
Valeri CR et al. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days. 2004 Transfusion pmid:15157253
Alexander J Proceedings: Inhibition of macrophage invasion by Leishmania mexicana promastigotes using cytochalasin B. 1974 Trans. R. Soc. Trop. Med. Hyg. pmid:4818664
Duff GW et al. The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. 1983 Trans. Assoc. Am. Physicians pmid:6093311
Korchak HM et al. Granulocytes without degranulation: neutrophil function in granule-depleted neutroplasts. 1983 Trans. Assoc. Am. Physicians pmid:6093314
Wright KM et al. Targeting of TMV movement protein to plasmodesmata requires the actin/ER network: evidence from FRAP. 2007 Traffic pmid:17132144
Glinsukon T and Lekutai S Comparative toxicity in the rat of cytochalasins B and E. 1979 Toxicon pmid:442102
Chang HT et al. Mechanisms underlying effect of the mycotoxin cytochalasin B on induction of cytotoxicity, modulation of cell cycle, Ca homeostasis and ROS production in human breast cells. 2016 Toxicology pmid:27640744
Bao L et al. Mutagenicity of diesel exhaust particles mediated by cell-particle interaction in mammalian cells. 2007 Toxicology pmid:17147977
Sandoval M et al. p53 response to arsenic exposure in epithelial cells: protein kinase B/Akt involvement. 2007 Toxicol. Sci. pmid:17567589
Goto K et al. Effect of nefiracetam, a neurotransmission enhancer, on primary uroepithelial cells of the canine urinary bladder. 2003 Toxicol. Sci. pmid:12604846
Loranger A et al. Effect of silybin on phalloidin-actin interactions in vitro. 1982 Toxicol. Lett. pmid:7090001
Glinsukon T et al. Cytochalasin E: inhibition of intestinal glucose absorption in the mouse. 1983 Toxicol. Lett. pmid:6836602
Kaneko M et al. Lithocholic acid-sensitive mutant cells isolated from Chinese hamster ovary cells are cross-sensitive to cytoskeleton-disturbing agents. 1993 Toxicol. Lett. pmid:8097340
Wong K et al. Differential effect of diltiazem and TA-3090 on calcium homeostasis of neutrophils. 1991 Toxicol. Appl. Pharmacol. pmid:1848029
Reist RH et al. Inhibition of proliferative activity of pulmonary fibroblasts by tetrandrine. 1993 Toxicol. Appl. Pharmacol. pmid:8104360
Mills JW and Ferm VH Effect of cadmium on F-actin and microtubules of Madin-Darby canine kidney cells. 1989 Toxicol. Appl. Pharmacol. pmid:2683216
Tithof PK et al. Aroclor 1242 stimulates the production of inositol phosphates in polymorphonuclear neutrophils. 1995 Toxicol. Appl. Pharmacol. pmid:7878669
Noel S et al. Evaluation of apigenin using in vitro cytochalasin blocked micronucleus assay. 2006 Toxicol In Vitro pmid:16759833